127 related articles for article (PubMed ID: 12016390)
21. Histological grade, p53, HER2 and hormone receptor status of synchronous bilateral breast carcinoma.
Matsuo K; Fukutomi T; Akashi-Tanaka S; Hasegawa T; Tsuda H
Breast Cancer; 2002; 9(2):127-33. PubMed ID: 12016392
[TBL] [Abstract][Full Text] [Related]
22. Expression of p53, epidermal growth factor receptor, c-erbB2 in oral leukoplakias and oral squamous cell carcinomas.
Singla S; Singla G; Zaheer S; Rawat DS; Mandal AK
J Cancer Res Ther; 2018; 14(2):388-393. PubMed ID: 29516925
[TBL] [Abstract][Full Text] [Related]
23. The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years.
Reed W; Hannisdal E; Boehler PJ; Gundersen S; Host H; Marthin J
Cancer; 2000 Feb; 88(4):804-13. PubMed ID: 10679650
[TBL] [Abstract][Full Text] [Related]
24. Apocrine adenosis: a precursor of aggressive breast cancer?
Wells CA; McGregor IL; Makunura CN; Yeomans P; Davies JD
J Clin Pathol; 1995 Aug; 48(8):737-42. PubMed ID: 7560201
[TBL] [Abstract][Full Text] [Related]
25. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
Barbareschi M; Leonardi E; Mauri FA; Serio G; Dalla Palma P
Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma.
Ferrari S; Bertoni F; Zanella L; Setola E; Bacchini P; Alberghini M; Versari M; Bacci G
Cancer; 2004 May; 100(9):1936-42. PubMed ID: 15112275
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
[TBL] [Abstract][Full Text] [Related]
28. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
29. [Immunohistochemical study of PCNA, EGFR, c-erbB-2 and p53 in carcinomas of large intestine].
Yamagiwa H; Onishi N; Onishi T; Onishi T; Onishi H; Watanabe K; Kadowaki Y; Nishii M; Kato Y
Rinsho Byori; 1995 Jul; 43(7):703-7. PubMed ID: 7674543
[TBL] [Abstract][Full Text] [Related]
30. The Role of EGFR, Hepatocyte Growth Factor Receptor (c-Met), c-ErbB2 (HER2-neu) and Clinicopathological Parameters in the Pathogenesis and Prognosis of Chordoma.
Tosuner Z; Bozkurt SU; Kiliç T; Yilmaz B
Turk Patoloji Derg; 2017; 33(2):112-120. PubMed ID: 28272674
[TBL] [Abstract][Full Text] [Related]
31. Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.
Lipponen P; Eskelinen M
Br J Cancer; 1994 Jun; 69(6):1120-5. PubMed ID: 7911031
[TBL] [Abstract][Full Text] [Related]
32. Epidermal growth factor receptor status in breast cancer metastases to the central nervous system. Comparison with HER-2/neu status.
Grupka NL; Lear-Kaul KC; Kleinschmidt-DeMasters BK; Singh M
Arch Pathol Lab Med; 2004 Sep; 128(9):974-9. PubMed ID: 15335267
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of the coexpression of p53 protein and c-erbB2 in breast cancer.
Tsutsui S; Ohno S; Murakami S; Kataoka A; Kinoshita J; Hachitanda Y
Am J Surg; 2003 Feb; 185(2):165-7. PubMed ID: 12559449
[TBL] [Abstract][Full Text] [Related]
34. Is c-erb B-2 a predictor for recurrent disease in early stage breast cancer?
Pierce LJ; Merino MJ; D'Angelo T; Barker EA; Gilbert L; Cowan KH; Steinberg SM; Glatstein E
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(2):395-403. PubMed ID: 7903962
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas.
Gulati S; Ytterhus B; Granli US; Gulati M; Lydersen S; Torp SH
Diagn Pathol; 2010 Mar; 5():18. PubMed ID: 20331873
[TBL] [Abstract][Full Text] [Related]
36. Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder.
Wright C; Mellon K; Johnston P; Lane DP; Harris AL; Horne CH; Neal DE
Br J Cancer; 1991 Jun; 63(6):967-70. PubMed ID: 1712624
[TBL] [Abstract][Full Text] [Related]
37. Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.
Ross JS; Gay LM; Wang K; Ali SM; Chumsri S; Elvin JA; Bose R; Vergilio JA; Suh J; Yelensky R; Lipson D; Chmielecki J; Waintraub S; Leyland-Jones B; Miller VA; Stephens PJ
Cancer; 2016 Sep; 122(17):2654-62. PubMed ID: 27284958
[TBL] [Abstract][Full Text] [Related]
38. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.
Gasparini G; Weidner N; Bevilacqua P; Maluta S; Dalla Palma P; Caffo O; Barbareschi M; Boracchi P; Marubini E; Pozza F
J Clin Oncol; 1994 Mar; 12(3):454-66. PubMed ID: 7509851
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical typing of non-small cell lung cancer on cryostat sections: correlation with clinical parameters and prognosis.
Hilbe W; Dirnhofer S; Oberwasserlechner F; Eisterer W; Ammann K; Schmid T; Hilbe G; Thaler J; Wöll E
J Clin Pathol; 2003 Oct; 56(10):736-41. PubMed ID: 14514775
[TBL] [Abstract][Full Text] [Related]
40. Comparison of immunohistological parameters in primary breast cancers and corresponding locoregional recurrences.
Rom J; Aulmann S; Schneeweiss A; Sohn C; Sinn HP
Pathol Res Pract; 2006; 202(3):125-30. PubMed ID: 16458445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
